Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
42.88
-1.28 (-2.90%)
At close: May 15, 2026, 4:00 PM EDT
42.90
+0.02 (0.05%)
After-hours: May 15, 2026, 5:57 PM EDT
Bruker Revenue
Bruker had revenue of $823.40M in the quarter ending March 31, 2026, with 2.75% growth. This brings the company's revenue in the last twelve months to $3.46B, up 0.36% year-over-year. In the year 2025, Bruker had annual revenue of $3.44B with 2.08% growth.
Revenue (ttm)
$3.46B
Revenue Growth
+0.36%
P/S Ratio
1.94
Revenue / Employee
$311,998
Employees
11,085
Market Cap
6.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.44B | 70.10M | 2.08% |
| Dec 31, 2024 | 3.37B | 401.90M | 13.56% |
| Dec 31, 2023 | 2.96B | 433.80M | 17.14% |
| Dec 31, 2022 | 2.53B | 112.80M | 4.67% |
| Dec 31, 2021 | 2.42B | 430.40M | 21.66% |
| Dec 31, 2020 | 1.99B | -85.10M | -4.11% |
| Dec 31, 2019 | 2.07B | 177.00M | 9.34% |
| Dec 31, 2018 | 1.90B | 129.70M | 7.34% |
| Dec 31, 2017 | 1.77B | 154.60M | 9.59% |
| Dec 31, 2016 | 1.61B | -12.50M | -0.77% |
| Dec 31, 2015 | 1.62B | -185.10M | -10.23% |
| Dec 31, 2014 | 1.81B | -30.50M | -1.66% |
| Dec 31, 2013 | 1.84B | 48.00M | 2.68% |
| Dec 31, 2012 | 1.79B | 139.70M | 8.46% |
| Dec 31, 2011 | 1.65B | 346.80M | 26.58% |
| Dec 31, 2010 | 1.30B | 190.40M | 17.08% |
| Dec 31, 2009 | 1.11B | 7.40M | 0.67% |
| Dec 31, 2008 | 1.11B | 74.70M | 7.24% |
| Dec 31, 2007 | 1.03B | 181.00M | 21.26% |
| Dec 31, 2006 | 851.40M | 479.15M | 128.72% |
| Dec 31, 2005 | 372.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Smith & Nephew | 6.16B |
| Globus Medical | 3.10B |
| Insulet | 2.90B |
| Bio-Rad Laboratories | 2.59B |
| Bio-Rad Laboratories | 2.59B |
| Integer Holdings | 1.86B |
| Masimo | 1.56B |
| Penumbra | 1.45B |
BRKR News
- 7 days ago - Bruker price target raised to $45 from $40 at Stifel - TheFly
- 8 days ago - Bruker price target raised to $45 from $43 at TD Cowen - TheFly
- 8 days ago - Bruker price target raised to $45 from $40 at UBS - TheFly
- 8 days ago - Bruker price target raised to $53 from $45 at Barclays - TheFly
- 8 days ago - Bruker price target raised to $44 from $40 at Citi - TheFly
- 9 days ago - Bruker reports Q1 adjusted EPS 31c, consensus 23c - TheFly
- 9 days ago - Bruker backs FY26 adjusted EPS view $2.10-$2.15, consensus $2.12 - TheFly
- 9 days ago - Bruker Earnings Call Transcript: Q1 2026 - Transcripts